Non-small Cell Lung Cancer (NSCLC), Stage IV Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic

IndicationStatusPhase
DBCOND0087270 (Non-small Cell Lung Cancer (NSCLC), Stage IV)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03769103Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLCTreatment